109 related articles for article (PubMed ID: 9061283)
1. Detection of sequential genetic alterations relevant for breast cancer development.
Niederacher D; Schnürch HG; An HX; Ellenberger I; Dall P; van Roeyen CR; Küppers V; Beckmann MW
Eur J Cancer Prev; 1996 Dec; 5(6):497-503. PubMed ID: 9061283
[TBL] [Abstract][Full Text] [Related]
2. Absence of genetic abnormalities in fibroadenomas of the breast determined at p53 gene mutations and microsatellite alterations.
Franco N; Picard SF; Mege F; Arnould L; Lizard-Nacol S
Cancer Res; 2001 Nov; 61(21):7955-8. PubMed ID: 11691818
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of genomic alterations in minimal residual cancer cells purified from the blood of breast cancer patients.
Austrup F; Uciechowski P; Eder C; Böckmann B; Suchy B; Driesel G; Jäckel S; Kusiak I; Grill HJ; Giesing M
Br J Cancer; 2000 Dec; 83(12):1664-73. PubMed ID: 11104564
[TBL] [Abstract][Full Text] [Related]
4. Genetic alteration mapping on chromosome 7 in primary breast cancer.
Bièche I; Khodja A; Driouch K; Lidereau R
Clin Cancer Res; 1997 Jun; 3(6):1009-16. PubMed ID: 9815778
[TBL] [Abstract][Full Text] [Related]
5. Loss and gain of distinct regions of chromosome 1q in primary breast cancer.
Bièche I; Champème MH; Lidereau R
Clin Cancer Res; 1995 Jan; 1(1):123-7. PubMed ID: 9815894
[TBL] [Abstract][Full Text] [Related]
6. Genetic pathways of two types of gastric cancer.
Tahara E
IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
[TBL] [Abstract][Full Text] [Related]
7. Four regions of allelic imbalance on 17q12-qter associated with high-grade breast tumors.
Plummer SJ; Paris MJ; Myles J; Tubbs R; Crowe J; Casey G
Genes Chromosomes Cancer; 1997 Dec; 20(4):354-62. PubMed ID: 9408751
[TBL] [Abstract][Full Text] [Related]
8. Gene and chromosomal alterations in sporadic breast cancer: correlation with histopathological features and implications for genesis and progression.
Tsuda H
Breast Cancer; 2009; 16(3):186-201. PubMed ID: 19472036
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity at 17p13.3-ter, distal to TP53, correlates with negative hormonal phenotype in sporadic breast cancer.
Roncuzzi L; Brognara I; Baiocchi D; Amadori D; Gasperi-Campani A
Oncol Rep; 2005 Aug; 14(2):471-4. PubMed ID: 16012732
[TBL] [Abstract][Full Text] [Related]
10. [Clinical value of gene diagnosis in breast cancer].
Iwase H
Rinsho Byori; 1998 Sep; 46(9):869-75. PubMed ID: 9800471
[TBL] [Abstract][Full Text] [Related]
11. Presence of tumor DNA in plasma of breast cancer patients: clinicopathological correlations.
Silva JM; Dominguez G; Garcia JM; Gonzalez R; Villanueva MJ; Navarro F; Provencio M; San Martin S; España P; Bonilla F
Cancer Res; 1999 Jul; 59(13):3251-6. PubMed ID: 10397273
[TBL] [Abstract][Full Text] [Related]
12. Double heterozygosity for mutations in the BRCA1 and BRCA2 genes in a breast cancer patient.
Tsongalis GJ; Linfert DR; Johnson RC; Ackroyd R; Berman MM; Ricci A
Arch Pathol Lab Med; 1998 Jun; 122(6):548-50. PubMed ID: 9625424
[TBL] [Abstract][Full Text] [Related]
13. Analysis of p53 gene mutation by polymerase chain reaction-single strand conformation polymorphism provides independent prognostic information in node-negative breast cancer.
Iacopetta B; Grieu F; Powell B; Soong R; McCaul K; Seshadri R
Clin Cancer Res; 1998 Jul; 4(7):1597-602. PubMed ID: 9676832
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis.
Shen CY; Yu JC; Lo YL; Kuo CH; Yue CT; Jou YS; Huang CS; Lung JC; Wu CW
Cancer Res; 2000 Jul; 60(14):3884-92. PubMed ID: 10919664
[TBL] [Abstract][Full Text] [Related]
15. Detection of plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis.
Coulet F; Blons H; Cabelguenne A; Lecomte T; Lacourreye O; Brasnu D; Beaune P; Zucman J; Laurent-Puig P
Cancer Res; 2000 Feb; 60(3):707-11. PubMed ID: 10676657
[TBL] [Abstract][Full Text] [Related]
16. Interest of investigating p53 status in breast cancer by four different methods.
Thirion A; Rouanet P; Thezenas S; Detournay D; Grenier J; Lopez-Crapez E
Oncol Rep; 2002; 9(6):1167-72. PubMed ID: 12375013
[TBL] [Abstract][Full Text] [Related]
17. Allelic loss at BRCA1, BRCA2, and adjacent loci in relation to TP53 abnormality in breast cancer.
Tseng SL; Yu IC; Yue CT; Chang SF; Chang TM; Wu CW; Shen CY
Genes Chromosomes Cancer; 1997 Dec; 20(4):377-82. PubMed ID: 9408754
[TBL] [Abstract][Full Text] [Related]
18. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
[TBL] [Abstract][Full Text] [Related]
19. Novel somatic mutations in the BRCA1 gene in sporadic breast tumors.
Janatova M; Zikan M; Dundr P; Matous B; Pohlreich P
Hum Mutat; 2005 Mar; 25(3):319. PubMed ID: 15712267
[TBL] [Abstract][Full Text] [Related]
20. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
Xu XF; Tang PZ; Cheng SJ
Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]